Home > Boards > US Listed > Miscellaneous > TherapeuticsMD, Inc. (TXMD)

Continuos failure after years of pumping. This Company

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JCB5 Member Profile
 
Followed By 46
Posts 5,448
Boards Moderated 0
Alias Born 04/16/08
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 2:30:38 PM
TherapeuticsMD to Host Investor and Analyst Day Today Business Wire - 6/10/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 7:16:23 AM
TherapeuticsMD & Theramex Enter into Exclusive License & Supply Agreement to Commercialize BIJUVA™ & IMVEXXY® Outside the ... Business Wire - 6/7/2019 7:15:00 AM
TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City Business Wire - 5/29/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/15/2019 5:29:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 7:03:21 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 6:01:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 5:06:06 PM
TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference Business Wire - 5/8/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2019 4:09:18 PM
TherapeuticsMD Announces First Quarter 2019 Financial Results Business Wire - 5/6/2019 4:05:00 PM
TherapeuticsMD Presented New Research at the American College of Obstetricians & Gynecologists 2019 Annual Meeting that Explo... Business Wire - 5/6/2019 7:00:00 AM
TherapeuticsMD Announces Oral & Poster Presentations on BIJUVA™ & ANNOVERA™ at the American College of Obstetricians & Gy... Business Wire - 5/3/2019 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 6:21:37 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 6:04:21 AM
TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019 Business Wire - 4/29/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/25/2019 4:36:00 PM
TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners Business Wire - 4/24/2019 4:10:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/17/2019 4:09:52 PM
TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Stre... Business Wire - 4/17/2019 7:05:00 AM
TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S. Business Wire - 4/17/2019 7:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/10/2019 11:10:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/8/2019 7:02:02 AM
TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the Endocrine Society 2019 Annual Meet... Business Wire - 3/25/2019 7:00:00 AM
JCB5   Wednesday, 12/27/17 09:26:24 AM
Re: None
Post # of 407 
Continuos failure after years of pumping. This Company is still taking investors money for multi million dollar salaries. Looks like the shorts own this and paid analyst are losing credibility. SELL ALERT.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist